Evidence map›Paper›PMID 25346775›Full record

ArticleImmunome research2011

Immunogenic Consensus Sequence T helper Epitopes for a Pan-

Anne S De Groot, Matthew Ardito, Leonard Moise, Eric A Gustafson, Denice Spero, Gloria Tejada, William Martin

Open access · greenAbstract read
In one paragraph

Article in Immunome research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anne S De GrootEpiVax 146 Clifford St, Providence, RI 02903, USA ; Institute for Immunology and Informatics, University of Rhode Island, 80 Washington St., Providence, RI 02903, USA.
Matthew ArditoEpiVax 146 Clifford St, Providence, RI 02903, USA.
Leonard MoiseEpiVax 146 Clifford St, Providence, RI 02903, USA ; Institute for Immunology and Informatics, University of Rhode Island, 80 Washington St., Providence, RI 02903, USA.
Eric A GustafsonInstitute for Immunology and Informatics, University of Rhode Island, 80 Washington St., Providence, RI 02903, USA.
Denice SperoInstitute for Immunology and Informatics, University of Rhode Island, 80 Washington St., Providence, RI 02903, USA.
Gloria TejadaInstitute for Immunology and Informatics, University of Rhode Island, 80 Washington St., Providence, RI 02903, USA.
William MartinEpiVax 146 Clifford St, Providence, RI 02903, USA.
EpiVax (United States) · US

Funding

TRIAD Scientific Core: TRIAD ToolkitU19AI082642 · NIAID · UNIVERSITY OF RHODE ISLAND · PI MARTIN, WILLIAM D · 2009 to 2013
$13.0M
NIAID NIH HHS U19 AI082642
6 · The paper itself

Abstract

backgroundBiodefense vaccines against Category B bioterror agents

resultsImmunoinformatics analysis of 31

conclusionsOur results show it is possible to rapidly identify promiscuous T helper epitopes conserved across multiple

Identifiers

PMID25346775
PMCPMC4206550
OpenAlexW83184912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.